Chemoinformaics analysis of (4-(24-Hydroxyl-1-oxo-5-n-propyltetracosanyl)-phenol)
| Molecular Weight | 502.824 | nRot | 26 |
| Heavy Atom Molecular Weight | 444.36 | nRig | 7 |
| Exact Molecular Weight | 502.439 | nRing | 1 |
| Solubility: LogS | -4.116 | nHRing | 0 |
| Solubility: LogP | 10.522 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 96.19 |
| nHD | 2 | BPOL | 59.054 |
| QED | 0.098 |
| Synth | 2.872 |
| Natural Product Likeliness | 0.554 |
| NR-PPAR-gamma | 0.783 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -5.107 |
| MDCK | 0.0000066 |
| BBB | 0.005 |
| PPB | 0.974679 |
| VDSS | 2.264 |
| FU | 0.00355986 |
| CYP1A2-inh | 0.066 |
| CYP1A2-sub | 0.137 |
| CYP2c19-inh | 0.222 |
| CYP2c19-sub | 0.041 |
| CYP2c9-inh | 0.057 |
| CYP2c9-sub | 0.981 |
| CYP2d6-inh | 0.237 |
| CYP2d6-sub | 0.052 |
| CYP3a4-inh | 0.23 |
| CYP3a4-sub | 0.024 |
| CL | 5.146 |
| T12 | 0.104 |
| hERG | 0.52 |
| Ames | 0.012 |
| ROA | 0.016 |
| SkinSen | 0.974 |
| Carcinogencity | 0.021 |
| EI | 0.951 |
| Respiratory | 0.647 |
| NR-Aromatase | 0.232 |
| Antiviral | Yes |
| Prediction | 0.589141 |